Risk factors for severe infection in patients with hairy cell leukemia: A long-term study of 73 patients

European Journal of Haematology

Volumn 83, Issue 3, 2009, Pages 246-250

  Damaj, Ghandi ^a   Kuhnowski, Frédérique ^b   Marolleau, Jean Pierre ^a   Bauters, Francis ^b   Leleu, Xavier ^b   Yakoub Agha, Ibrahim ^b,c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Hairy cell leukemia; Infections; Risk factor

Indexed keywords

CLADRIBINE; HEMOGLOBIN; INTERFERON; PENTOSTATIN; RITUXIMAB;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CELL COUNT; FEMALE; FOLLOW UP; HAIRY CELL LEUKEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFECTION; INFECTION RATE; INFECTION RISK; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOCYTE; MULTIMODALITY CANCER THERAPY; MYCOSIS; NEUTROPHIL COUNT; OVERALL SURVIVAL; PATIENT MONITORING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RISK FACTOR; SEX RATIO; SPLENECTOMY; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; LEUKEMIA, HAIRY CELL; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; NUCLEOSIDES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 68849102602     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01259.x     Document Type: Article

References (13)

1. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood 1958 13 : 609 30.
2. Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 1995 13 : 974 82.
3. Saven A, Piro L. Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med 1994 330 : 691 7.
4. Goodman GR, Burian C, Koziol JA, et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003 21 : 891 6.
5. Zinzani PL, Tani M, Marchi E, et al. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Haematologica 2004 89 : 309 13.
6. Else M, Ruchlemer R, Osuji N, et al. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer 2005 104 : 2442 8.
7. Chadha P, Rademaker AW, Mendiratta P, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood 2005 106 : 241 6.
8. Maloisel F, Benboubker L, Gardembas M, et al. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia 2003 17 : 45 51.
9. Golomb HM, Hadad LJ. Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 1984 16 : 393 401.
10. Seshadri RS, Brown EJ, Zipursky A. Leukemic reticuloendotheliosis. A failure of monocyte production. N Engl J Med 1976 295 : 181 4.
11. Bourguin-Plonquet A, Rouard H, Roudot-Thoraval F, et al. Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia. Br J Haematol 2002 116 : 595 7.
12. Allsup DJ, Cawley JC. The diagnosis and treatment of hairy-cell leukaemia. Blood Rev 2002 16 : 255 62.
13. Ravandi F, Jorgensen JL, O'Brien SM, et al. Eradication of minimal residual disease in hairy cell leukemia. Blood 2006 107 : 4658 62.